Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

about

Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

Item

http://www.wikidata.org/entity/Q57729876

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2012

@uk

name

Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

@en

Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

@nl

type

Item

label

Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

@en

Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

@nl

prefLabel

Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

@en

Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

@nl

P1476

Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide

@en

P2093

Alaa El-Din M. Gaafar

http://www.w3.org/2001/XMLSchema#string

Marwa El-Sayed El-Shamarka

http://www.w3.org/2001/XMLSchema#string

Nermeen Shaffee

http://www.w3.org/2001/XMLSchema#string

Omar M. E. Abdel-Salam

http://www.w3.org/2001/XMLSchema#string

P2860

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

Tissue sulfhydryl groups

Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Human PON1, a biomarker of risk of disease and exposure

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.

Pathogenesis of liver fibrosis: role of oxidative stress.

The use of silymarin in the treatment of liver diseases.

P304

495-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00580-012-1641-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime